| # |
Peptide |
Category |
Dose Range |
Route |
Grade |
Protocol |
| 1 |
BPC-157 |
Tissue Repair |
250-500mcg/day |
Subcutaneous |
A |
View → |
| 2 |
Semaglutide |
Weight Management |
0.25-2.4mg/wk |
Subcutaneous |
A |
View → |
| 3 |
Tirzepatide |
Dual GLP-1/GIP |
2.5-15mg/wk |
Subcutaneous |
A |
View → |
| 4 |
TB-500 |
Recovery / Healing |
2-5mg/wk loading |
Subcutaneous |
B+ |
View → |
| 5 |
CJC-1295 / Ipamorelin |
GH Release |
100-300mcg each |
Subcutaneous |
B+ |
View → |
| 6 |
MK-677 |
Oral GH Secretagogue |
10-25mg/day |
Oral |
B+ |
View → |
| 7 |
PT-141 |
Sexual Function |
1-2mg as needed |
Subcutaneous |
B |
View → |
| 8 |
GHK-Cu |
Skin / Collagen |
1-2mg/day |
Subcutaneous / Topical |
B |
View → |
| 9 |
Semax |
Cognitive |
200-600mcg intranasal |
Intranasal |
B |
View → |
| 10 |
Epithalon |
Anti-Aging |
5-10mg/day x10d |
Subcutaneous |
B- |
View → |
Grade Key:
A Strong clinical/preclinical data
B+ Good supporting evidence
B Moderate evidence
B- Emerging evidence
Disclaimer: This reference is for research and educational purposes only. Peptide regulatory status varies by jurisdiction. Always consult a qualified healthcare professional and verify current regulations before beginning any protocol.